Morrissey G J, Gravelle D, Dietz G, Driedger A A, King M, Cradduck T D
Department of Nuclear Medicine, Victoria Hospital, London, Ont., Canada.
J Nucl Med. 1988 May;29(5):684-8.
In vivo radionuclide crossmatch is a method for identifying compatible blood for transfusion when allo- or autoantibodies preclude the use of conventional crossmatching techniques. A technique for labeling small volumes of donor red blood cells with [113mIn]tropolone is reported. The use of 113mIn minimizes the accumulation of background radioactivity and the radiation dose especially so when multiple crossmatches are performed. Labeling red cells with [113mIn]tropolone is faster and easier to perform than with other radionuclides. Consistently high labeling efficiencies are obtained and minimal 113mIn activity elutes from the labeled red blood cells. A case study involving 22 crossmatches is presented to demonstrate the technique. The radiation dose equivalent from 113mIn is significantly less than with other radionuclides that may be used to label red cells.
体内放射性核素交叉配血是一种在同种或自身抗体排除传统交叉配血技术使用时,识别相容输血用血的方法。本文报道了一种用[113m铟]托品酮标记少量供体红细胞的技术。使用113m铟可将本底放射性的积累和辐射剂量降至最低,尤其是在进行多次交叉配血时。用[113m铟]托品酮标记红细胞比用其他放射性核素更快、更容易操作。标记效率始终很高,且标记红细胞洗脱的113m铟活性最低。本文通过一个涉及22次交叉配血的案例研究来演示该技术。113m铟产生的辐射剂量当量明显低于可用于标记红细胞的其他放射性核素。